Proteomics

Dataset Information

0

Identification of the initial molecular changes in response to Circulating Angiogenic Cells-mediated therapy in Critical Limb Ischemia


ABSTRACT: Circulating angiogenic cells (CACs) constitute promising candidates for cell therapy in critical limb ischemia (CLI) due to their assigned vascular regenerative properties. A label free MS-based quantitative approach was performed to identify protein changes related. We analyzed the initial molecular mechanisms triggered by human CACs after being administered to a murine model of CLI, in order to understand how these cells promote angiogenesis within the ischemic tissue.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Leg Muscle

DISEASE(S): Cardiovascular System Disease

SUBMITTER: Lucía Beltrán-Camacho  

LAB HEAD: Mª Carmen Duran-Ruiz

PROVIDER: PXD017661 | Pride | 2020-05-27

REPOSITORIES: Pride

altmetric image

Publications


<h4>Background</h4>Critical limb ischemia (CLI) constitutes the most aggressive form of peripheral arterial occlusive disease, characterized by the blockade of arteries supplying blood to the lower extremities, significantly diminishing oxygen and nutrient supply. CLI patients usually undergo amputation of fingers, feet, or extremities, with a high risk of mortality due to associated comorbidities. Circulating angiogenic cells (CACs), also known as early endothelial progenitor cells, constitute  ...[more]

Similar Datasets

2022-02-16 | PXD024132 | Pride
2021-09-07 | PXD026954 | Pride
2016-07-21 | E-GEOD-84626 | biostudies-arrayexpress
2011-12-31 | E-GEOD-30138 | biostudies-arrayexpress
2016-07-21 | GSE84626 | GEO
2013-01-06 | E-GEOD-41691 | biostudies-arrayexpress
2016-05-31 | E-GEOD-81223 | biostudies-arrayexpress
2008-06-15 | E-GEOD-7598 | biostudies-arrayexpress
2021-10-06 | PXD021849 | JPOST Repository